Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A New Light-Emitting, Fabric-Based Device for Photodynamic Therapy of Actinic Keratosis: Protocol for a Randomized, Controlled, Multicenter, Intra-Individual, Phase II Noninferiority Study (the Phosistos Study).
Vignion-Dewalle AS, Abi Rached H, Thecua E, Lecomte F, Deleporte P, Béhal H, Hommel T, Duhamel A, Szeimies RM, Mortier L, Mordon S. Vignion-Dewalle AS, et al. Among authors: lecomte f. JMIR Res Protoc. 2019 Apr 26;8(4):e12990. doi: 10.2196/12990. JMIR Res Protoc. 2019. PMID: 31025953 Free PMC article.
Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp.
Vicentini C, Vignion-Dewalle AS, Thecua E, Lecomte F, Maire C, Deleporte P, Béhal H, Kerob D, Duhamel A, Mordon S, Mortier L. Vicentini C, et al. Among authors: lecomte f. Br J Dermatol. 2019 Apr;180(4):765-773. doi: 10.1111/bjd.17350. Epub 2019 Jan 18. Br J Dermatol. 2019. PMID: 30367470 Clinical Trial.
The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study.
Mordon S, Vignion-Dewalle AS, Abi-Rached H, Thecua E, Lecomte F, Vicentini C, Deleporte P, Béhal H, Kerob D, Hommel T, Duhamel A, Szeimies RM, Mortier L. Mordon S, et al. Among authors: lecomte f. Br J Dermatol. 2020 Jan;182(1):76-84. doi: 10.1111/bjd.18048. Epub 2019 Aug 1. Br J Dermatol. 2020. PMID: 31021404 Clinical Trial.
Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: How relevant are effective light dose and local damage in predicting the complete response rate at 3 months?
Vignion-Dewalle AS, Baert G, Thecua E, Lecomte F, Vicentini C, Abi-Rached H, Mortier L, Mordon S. Vignion-Dewalle AS, et al. Among authors: lecomte f. Lasers Surg Med. 2018 Jul;50(5):576-589. doi: 10.1002/lsm.22827. Epub 2018 Apr 18. Lasers Surg Med. 2018. PMID: 29667728
Photodynamic therapy for actinic keratosis of the forehead and scalp with the Aktilite CL 128: Is there a cut-off value for PpIX-weighted irradiance for effective treatment?
Vicentini C, Vignion-Dewalle AS, Thecua E, Lecomte F, Béhal H, Maire C, Tylcz JB, Abi-Rached H, Mortier L, Mordon S. Vicentini C, et al. Among authors: lecomte f. Photodermatol Photoimmunol Photomed. 2019 Jul;35(4):232-237. doi: 10.1111/phpp.12457. Epub 2019 Mar 12. Photodermatol Photoimmunol Photomed. 2019. PMID: 30762242 Clinical Trial.
163 results